SNDL Reports First Quarter 2023 Financial and Operational Results
Synergy targets related to the Valens acquisition increased to more than
SNDL has also posted a supplemental investor presentation on its website, which can be found at https://sndl.com.
FIRST QUARTER 2023 FINANCIAL AND OPERATIONAL HIGHLIGHTS
- Net revenue for the first quarter of 2023 of
, compared to$202.5 million in the fourth quarter of 2022, and$240.4 million in the first quarter of 2022, representing a 1,$17.6 million 050% increase year-over-year. The increase over the comparative quarter in the prior year is due to the acquisitions of Alcanna, Valens and Zenabis. The decrease in revenue in the first quarter of 2023, as compared to the fourth quarter of 2022, can be attributed to seasonality in the Liquor Retail segment, as the fourth quarter is traditionally the strongest and the first quarter is typically the weakest. This was partially offset by an increase in revenue from the Cannabis Operations segment due to the partial quarter contribution of Valens in 2023. - Liquor Retail: Net revenue of
for the first quarter of 2023.$115.9 million - Cannabis Retail: Net revenue of
for the first quarter of 2023.$67.4 million - Cannabis Operations: Net revenue of
for the first quarter of 2023.$19.1 million - Net loss of
for the first quarter of 2023, compared to a$36.1 million net loss in the fourth quarter of 2022, and a$161.6 million net loss in the first quarter of 2022. The loss for the first quarter was impacted by the seasonal downturn in Liquor Retail sales and inventory and asset impairments of$38.0 million .$10 million - Adjusted EBITDA of
for the first quarter of 2023, compared to a loss of$7.4 million in the fourth quarter of 2022, and a loss of$7.5 million from the first quarter of 2022.$0.7 million - Gross margin was
in the first quarter of 2023, compared to$32.5 million in the fourth quarter of 2022 and up$43.6 million 856% from the first quarter of 2022. Seasonality of liquor sales impacted gross margin for the first quarter of 2023 compared to the prior sequential quarter. - Closed the acquisition of Valens in January of 2023. The combined entities create a low-cost vertically integrated Canadian company with the capability of potentially generating over a billion dollars annually in pro forma revenue. Through the combination of a diverse portfolio of brands, a 197 store multi-banner cannabis retail network, low-cost biomass sourcing, premium indoor cultivation and low-cost manufacturing facilities, SNDL is one of the largest adult-use cannabis manufacturers and retailers in
Canada . - Since the close of the Valens acquisition, SNDL has achieved more than
in annual cost savings and has identified$13 million in additional annual cost savings to be achieved in 2023, exceeding management's original$5 million total target. By 2024, run-rate synergies are expected to exceed$10 million annually, and proceeds from asset sales are expected to total$30 million .$9 million - On May 5, 2023, SNDL announced that the proposed strategic partnership (the "Nova Restructuring") with its
63% owned subsidiary Nova Cannabis Inc. ("Nova") was approved by Nova's shareholders. The Nova Restructuring is designed to create a well-capitalized cannabis retail platform through a vertical integration model leveraging SNDL's upstream and midstream capabilities. The Nova Restructuring is expected to close before the end of June 2023. - SNDL currently has six credit exposures in the SunStream portfolio, including two under active negotiations regarding potential restructuring.
of unrestricted cash, marketable securities and long-term investments, and no outstanding debt at March 31, 2023, resulting in a net book value per share of$793 million ; and$5.26 of unrestricted cash at May 12, 2023. SNDL has not raised cash through share offerings since June 2021.$189.8 million
"We are pleased to report progress towards key milestones in all of our operative segments against the backdrop of expected seasonally moderate sales in our retail networks," said Zach George, Chief Executive Officer of SNDL. "The integration of Valens is proceeding with pace, and we are actively identifying new revenue streams and cost reduction opportunities. The first quarter was impacted by a number of one-time items including
FIRST QUARTER 2023 KEY FINANCIAL METRICS
OPERATING SEGMENTS | ||||||||
( | Liquor | Cannabis | Cannabis | Investments | Corporate | Total | ||
As at March 31, 2023 | ||||||||
Total assets | 327,072 | 202,921 | 333,439 | 734,934 | 19,380 | 1,617,746 | ||
Three months ended March 31, 2023 | ||||||||
Net revenue | 115,911 | 67,408 | 19,133 | — | — | 202,452 | ||
Gross margin | 26,267 | 15,819 | (9,545) | — | — | 32,541 | ||
Interest and fee revenue | — | — | — | 4,211 | — | 4,211 | ||
Investment (loss) income | — | — | (283) | (4,886) | — | (5,169) | ||
Share of profit of equity-accounted | — | — | — | 9,516 | — | 9,516 | ||
Depreciation and amortization | 10,346 | 3,690 | 1,146 | — | 1,286 | 16,468 | ||
Income (loss) before income tax | (2,963) | (744) | (19,120) | 5,370 | (17,321) | (34,778) | ||
As at December 31, 2022 | ||||||||
Total assets | 351,338 | 200,393 | 163,130 | 825,151 | 19,338 | 1,559,350 | ||
Three months ended March 31, 2022 | ||||||||
Net revenue | 1,310 | 7,512 | 8,775 | — | — | 17,597 | ||
Gross margin | 284 | 3,293 | (158) | — | — | 3,419 | ||
Interest and fee revenue | — | — | — | 3,861 | — | 3,861 | ||
Investment loss | — | — | — | (17,710) | — | (17,710) | ||
Share of profit of equity-accounted | — | — | — | 4,091 | — | 4,091 | ||
Depreciation and amortization | — | 595 | 9 | — | 135 | 739 | ||
Income (loss) before income tax | (73) | (280) | (2,964) | (9,695) | (25,028) | (38,040) |
FIRST QUARTER 2023 RESULTS
SNDL's business is operated and reported in four segments: Liquor Retail, Cannabis Retail, Cannabis Operations and Investments.
Liquor Retail
SNDL is
- Gross revenue for Liquor Retail sales for the three banners combined was
for the first quarter of 2023, a decrease of$115.9 million 27% compared to the fourth quarter of 2022. The first quarter of 2022 had results from only one day subsequent to the Alcanna acquisition. - Gross margin in the Liquor Retail segment was
, or$26.3 million 23% of sales in the first quarter of 2023, compared to , or$36.9 million 23% of sales, in the fourth quarter of 2022. Through strategic planning and effective execution, the Company actively managed its margin during the first quarter by strongly emphasizing its preferred label program. As a result, preferred label sales make up10% of total sales in the first quarter of 2023. Preferred label sales were in the first quarter of 2023, compared to$11.2 million in the fourth quarter of 2022. Preferred label margin continues to be incrementally higher than the Company's baseline margin, and the current preferred label margin is$14.0 million , or$3.2 million 29% of sales. The Company is seeing the continued benefits of this strategy subsequent to quarter end, with the margin on all products reaching24% in April of 2023. - SNDL's liquor banners' market share in
Alberta was approximately18% in the first quarter of 2023, with Wine and Beyond representing approximately3% from only 11 stores in the province, showcasing the continued success of the banner. Sales at the Wine and Beyond inKelowna, British Columbia continue to increase year-over-year, further validating the banner's expansion strategy into new markets. - SNDL successfully obtained two liquor retail licenses in
Regina andSaskatoon through the Saskatchewan Liquor and Gaming Authority auction. The Company will leverage these licenses to further expand its premium liquor banner, Wine and Beyond, into the final stage of the liquor retail transition to the private sector inSaskatchewan . - As of May 12, 2023, the Ace Liquor store count is 138, the Liquor Depot store count is 20, and the Wine and Beyond store count is 12.
Cannabis Retail
With its ownership interest in Nova, SNDL is
- Gross revenue from the Cannabis Retail segment for the first quarter of 2023 was
, compared to$67.4 million in the fourth quarter of 2022, showing a modest seasonal dip, and up from$68.4 million in the first quarter of 2022. The Nova acquisition and Value Buds sales were the material driver of the increase relative to the first quarter of 2022, with$7.5 million of revenue during the first quarter of 2023.$60.2 million - Gross margin of
, or$15.8 million 23% of sales, consistent with the fourth quarter of 2022 gross margin. The increase in gross margin compared to the first quarter of 2022 was primarily due to the acquisition of Nova and the addition of new Value Buds locations during those 12 months, combined with a more aggressive pricing strategy. - In the first quarter of 2023, SNDL took proactive steps to optimize its proprietary data licensing program for the Cannabis Retail segment, aiming to create mutually beneficial results for its retail operations and licensed producer partners. The Company is optimistic that the optimized data licensing program will support the growth of the segment and create additional margin accretive opportunities. By leveraging the volume of Nova's retail locations and the Company's access to high-quality analytics, it expects to deliver successful outcomes for its partners and drive top-line growth.
- In the first quarter of 2023, Value Buds, Spiritleaf, and Superette's combined market share represents approximately
9.6% in the privatized provincial markets, solidifying SNDL's position as a leading national multi-banner cannabis retail operator in an increasingly competitive market. - The Company partnered with Nova for Value Buds' private label products, and sales of Value Buds products represented approximately
8.1% of total 28-gram sales and36.3% of 14-gram sales in Alberta Value Buds stores for the period ended March 31, 2023. Private label margins are approximately5% higher than margins on comparable competitor products. - On May 5, 2023, SNDL's proposed strategic partnership with Nova was approved by Nova shareholders to create a well-capitalized cannabis retail platform through a vertical integration model leveraging SNDL's upstream and midstream capabilities.
- In February 2023, SNDL announced the acquisition of five Superette stores in
Ontario . - The Company entered into an agreement with Lightbox Enterprises Ltd. ("Lightbox") to acquire four cannabis retail stores operating under the Dutch Love Cannabis banner ("Dutch Love"). The transaction is anticipated to close by the end of June 2023.
- As of May 12, 2023, the Spiritleaf store count is 99 (22 corporate stores and 77 franchise stores), the Superette store count is five corporate stores, the Firesale store count is two corporate stores, and the Value Buds store count is 92 corporate stores.
Cannabis Operations
SNDL has a diverse brand portfolio from value to premium, emphasizing premium inhalable formats and a full suite of 2.0 products. With enhanced procurement capabilities, premium cultivation facilities and the newly acquired
- Gross revenue from the Cannabis Operations segment for the first quarter of 2023 was
, a$29.6 million 58% increase compared to the fourth quarter of 2022 and a162% increase compared to the first quarter of 2022. - Gross Margin was negative
including a$9.5 million inventory impairment provision, compared to negative$9.2 million in the fourth quarter of 2022 and negative$9.0 million in the first quarter of 2022. The current quarter's inventory impairment is a direct consequence of the ongoing refocusing and reorganization of the segment with the Valens expansion.$0.2 million - Following the Valens acquisition, SNDL announced changes to its operations through a rightsizing of cannabis cultivation in
Olds, Alberta , to focus the facility on premium products and brands and to better address market saturation, oversupply and efficiency. The Company's ongoing focus on high-quality cannabis cultivation operations and its low-cost biomass procurement capabilities enhance SNDL's ability to offer a wide range of customized, innovative products to meet customer demand and current market conditions. - Effective May 1, SNDL has successfully transitioned all midstream production operations to the Company's facility in
Kelowna , including processing, labelling and excising activities. By reducing reliance on high-cost cannabis production and centralizing operations, the Company expects to increase efficiency and manage cash flow more effectively. - As part of SNDL's commitment to effectively address market demand, the Company is in the process of rationalizing its SKU portfolio. By focusing on high-margin products and continuing to drive innovation, the Company expects to see better margins for the Cannabis Operations segment in the upcoming quarters. This approach is designed to allow the Company to optimize its resources and achieve its long-term goals while maintaining a competitive edge in the market.
- In the first quarter of 2023, SNDL has realized an increase in its business-to-business ("B2B") revenue and has established partnerships with most of the major Canadian licensed producers. SNDL is actively exploring opportunities for international export business and is committed to identifying new SKUs to meet the unique demands of its global partners. The Company is investing in process improvements and testing capabilities to ensure it can meet the rigorous standards of its international partners.
Investments
- As of the end of the first quarter of 2023, the Company had deployed capital on a portfolio of cannabis-related investments with a carrying value of
, including$579.9 million through the SunStream Bancorp Inc. joint venture ("SunStream").$535.9 million - For the first quarter of 2023, the investment portfolio generated interest and fee revenue of
, share of profit of equity-accounted investees generated from investments by SunStream of$4.2 million , and an investment loss of$9.5 million , on marketable securities, which includes unrealized losses on its publicly disclosed strategic investment in Village Farms International, Inc.$5.2 million - SunStream's credit portfolio currently consists of six investments: Jushi Holdings, SKYMINT Brands, Ascend Wellness Holdings, Parallel, Inc., Columbia Care Inc. and AFC Gamma, Inc.
- The Company continues to explore the potential monetization or equitization of some of its US senior credits. The Company is proactively pursuing opportunities to enhance its assets and generate higher earnings through strategic initiatives, recognizing their significant potential to create value.
Three months ended | ||
( | 2023 | 2022 |
Interest and fee revenue | ||
Interest revenue from investments at amortized cost | 1,006 | 995 |
Interest and fee revenue from investments at Fair Value Through Profit or Loss | 624 | 2,116 |
Interest revenue from cash | 2,581 | 750 |
4,211 | 3,861 | |
Investment revenue (loss) | ||
Realized (losses) gains | (43,804) | 124 |
Unrealized gains (losses) | 38,635 | (17,834) |
(5,169) | (17,710) | |
Revenue from direct investments | (958) | (13,849) |
Share of profit (loss) of equity-accounted investees | 9,516 | 4,091 |
Total investment activities | 8,558 | (9,758) |
Consolidated Financial Results
- General and administrative expenses for the three months ended March 31, 2023, were
compared to$48.6 million for the three months ended March 31, 2022. The increase of$10.7 million was mainly due to increases in salaries and wages, office and general expenses, professional fees and merchant processing fees as a result of the Valens and Alcanna acquisitions.$37.9 million - Net loss from continuing operations for the three months ended March 31, 2023, was
compared to$34.8 million for the three months ended March 31, 2022. The decrease in net loss from continuing operations of$38.0 million was largely due to an increase in gross margin ($3.2 million ), lower investment losses ($29.2 million ), increased share of profit of equity-accounted investees ($12.5 million ), lower transaction costs ($5.4 million ) and change in fair value of derivative warrants ($4.4 million ), partially offset by higher general and administrative expenses ($13.1 million ), depreciation and amortization ($37.9 million ) and finance costs ($15.7 million ).$5.2 million
Liquidity Position
- As at March 31, 2023, and May 12, 2023, the Company had unrestricted cash balances of
and$213.3 million , respectively, and a total of 260 million shares outstanding as at May 12, 2023.$189.8 million - During the first quarter of 2023, a total of
cash was used in operating activities, which included$48.9 million to replenish liquor inventory following the seasonal holiday draw in the fourth quarter of 2022,$13.5 million in severance and restructuring costs, and$2.7 million to stabilize Valens' cash position and bring overdue accounts payable up to date. This included addressing unpaid liabilities, such as$17.5 million in excise tax, which had accumulated prior to the acquisition date. The lower gross profit from the liquor segment in the first quarter also contributed to the use of cash during the quarter.$4.9 million - The Company's share repurchase program continues to be available to lower the outstanding share float and increase the earnings per share for shareholders. However, due to an ongoing blackout period, the Company has been unable to repurchase shares in recent months. As SNDL comes out of the blackout period, it will assess opportunities to utilize the program to the extent that management believes SNDL's shares are undervalued. For the three months ended March 31, 2023, the Company purchased and cancelled 0.5 million common shares at a weighted average price of
($2.78 US ) per common share for a total cost of$2.04 . SNDL's management team is committed to creating value for its shareholders and will continue to assess opportunities to repurchase shares in the future.$1.5 million
STRATEGIC AND ORGANIZATIONAL UPDATE
SNDL remains focused on building long-term shareholder value through vertical integration, accretive deployment of cash resources, expansion of its retail distribution network, further streamlining of the Company's operating structure and enhanced offerings of high-quality brands within both the Cannabis Operations and Cannabis Retail segments.
Integration Initiatives
The Company is pleased to report that the integration initiatives and cost synergies are progressing well, with more than
The management team expects these cost savings will positively impact operating expenses and drive margin expansion in the third and fourth quarters of 2023. SNDL remains committed to its integration initiatives and will continue to update shareholders on its progress.
SPECIFIED FINANCIAL MEASURES
Certain specified financial measures in this news release are non-IFRS measures. These terms are not defined by IFRS and, therefore, may not be comparable to similar measures provided by other companies. These non-IFRS financial measures should not be considered in isolation or as an alternative for or superior to measures of performance prepared in accordance with IFRS. These measures are presented and described to provide shareholders and potential investors with additional measures in understanding the Company's operating results in the same manner as the management team.
ADJUSTED EBITDA
Adjusted EBITDA is a non-IFRS measure which the Company uses to evaluate its operating performance. Adjusted EBITDA provides information to investors, analysts, and others to aid in understanding and evaluating the Company's operating results in a manner similar to its management team. Adjusted EBITDA is defined as net income (loss) from continuing operations before finance costs, depreciation and amortization, accretion expense, income tax recovery and excluding changes in fair value of biological assets, changes in fair value realized through inventory, unrealized foreign exchange gains or losses, unrealized gains or losses on marketable securities, realized gains or losses on investments resulting from business combinations, changes in fair value of derivative warrants, share-based compensation expense, asset impairment, gain or loss on disposal of property, plant and equipment and certain one-time non-operating expenses, as determined by management. The Company presents both consolidated, total Adjusted EBITDA and Adjusted EBITDA by operating segment.
OPERATING SEGMENTS | ||||||
( | Liquor | Cannabis | Cannabis | Investments | Corporate | Total |
Three months ended March 31, 2023 | ||||||
Net earnings (loss) | (2,963) | (744) | (19,120) | 5,370 | (17,321) | (34,778) |
Adjustments | ||||||
Finance costs | 1,011 | 666 | 129 | 3,367 | — | 5,173 |
Change in estimate of fair value of derivative | — | (2) | — | — | (4,800) | (4,802) |
Depreciation and amortization | 10,346 | 3,690 | 1,146 | — | 1,286 | 16,468 |
Change in fair value of biological assets | — | — | 3,535 | — | — | 3,535 |
Change in fair value realized through inventory | — | — | (950) | — | — | (950) |
Unrealized foreign exchange (gain) loss | — | — | 48 | — | — | 48 |
Unrealized (gain) loss on marketable | — | — | 283 | (38,918) | — | (38,635) |
Realized loss on marketable securities | — | — | — | 43,699 | — | 43,699 |
Share-based compensation | — | (11) | — | — | 2,220 | 2,209 |
Asset impairment | — | — | 807 | — | — | 807 |
Loss (gain) on disposition of PP&E | 14 | 25 | 145 | — | — | 184 |
Cost of sales non-cash component (1) | — | — | 1,704 | — | — | 1,704 |
Inventory impairment (recovery) and | — | — | 9,177 | — | — | 9,177 |
Restructuring costs | — | — | 89 | — | 1,447 | 1,536 |
Transaction costs | — | — | — | — | 2,040 | 2,040 |
Adjusted EBITDA | 8,408 | 3,624 | (3,007) | 13,518 | (15,128) | 7,415 |
(1) Cost of sales non-cash component is comprised of depreciation expense |
OPERATING SEGMENTS | ||||||
( | Liquor | Cannabis | Cannabis | Investments | Corporate | Total |
Three months ended March 31, 2022 | ||||||
Net earnings (loss) | (73) | (280) | (2,964) | (9,695) | (25,028) | (38,040) |
Adjustments | ||||||
Finance costs | — | — | — | — | (61) | (61) |
Change in estimate of fair value of derivative | — | — | — | — | 8,300 | 8,300 |
Depreciation and amortization | — | 595 | 9 | — | 135 | 739 |
Change in fair value of biological assets | — | — | (3,690) | — | — | (3,690) |
Change in fair value realized through inventory | — | — | 1,561 | — | — | 1,561 |
Unrealized foreign exchange (gain) loss | — | — | 16 | — | — | 16 |
Unrealized (gain) loss on marketable | — | — | — | 17,834 | — | 17,834 |
Share-based compensation | — | — | — | — | 4,204 | 4,204 |
Inventory impairment (recovery) and | — | — | 1,981 | — | — | 1,981 |
Transaction costs | — | — | — | — | 6,481 | 6,481 |
Adjusted EBITDA | (73) | 315 | (3,087) | 8,139 | (5,969) | (675) |
(1) Cost of sales non-cash component is comprised of depreciation expense |
This press release is intended to be read in conjunction with the Company's Financial Statements and Notes for the period ended March 31, 2023, and the accompanying Management's Discussion and Analysis ("MD&A"). These reports are available under the Company's profile on SEDAR at www.sedar.com and EDGAR at www.sec.gov/edgar.shtml.
CONFERENCE CALL
The Company will hold a conference call and webcast at 1 p.m. EST (11 a.m. MST) on Monday, May 15, 2023.
WEBCAST ACCESS
To access the live webcast of the call, please visit the following link:
https://services.choruscall.ca/links/sndl2023q1.html
REPLAY
A telephone replay will be available for one month. To access the replay, dial:
When prompted, enter Replay Access Code: 0166#
The webcast archive will be available for three months via the link provided above.
ABOUT SNDL INC.
SNDL is a public company whose shares are traded on the Nasdaq under the symbol "SNDL."
SNDL is the largest private-sector liquor and cannabis retailer in
Forward-Looking Information Cautionary Statement
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"), including, but not limited to, statements regarding the Company's operational goals, demand for the Company's products, the Company's ability to achieve profitability or its goal of sustainable, positive gross margin and positive free cash flow, the development of the legal cannabis industry, performance of the Company's investments, including through the SunStream joint venture, any potential forms of shareholder value creation, the ability to realize expected cost savings and the expansion of product offerings, brand and market share and retail networks, and the closing, integration and realization of expected benefits of, as applicable, the acquisition of The Valens Company, Zenabis and Superette. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "likely", "outlook", "forecast", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Please see "Item 3.D.—Risk Factors" in the Company's annual report on Form 20-F, filed with the Securities and Exchange Commission ("SEC") on April 24, 2023, and the risk factors included in our other SEC filings for a discussion of the material risk factors that could cause actual results to differ materially from the forward-looking information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/sndl-reports-first-quarter-2023-financial-and-operational-results-301824249.html
SOURCE Sundial Growers Inc.